| Unrestricted | Unrestricted | |||||
|---|---|---|---|---|---|---|
| Note | Funds | Funds | ||||
| 2023 | 2022 | |||||
| 2 | 2 | |||||
| Income | ||||||
| Investment | income | 110,080 | 93,061 | |||
| Total | 110,080 | 93,061 | ||||
| Expenditure | ||||||
| Raising funds | (5,537) | (8,015) | ||||
| Charitable activities |
(73,783) | (28,589) | ||||
| Total | (79,320) | (36,604) | ||||
| Net income investments |
before gains and losses on | 30,760 | 56,457 | |||
| Net (losses) | Igains on | investments | (24,326) | 151,759 | ||
| Net movement | in funds | 6,434 | 208,216 | |||
| Fund balance | brought | forward | 2,871,360 | 2,663,144 | ||
| Fund balance | carried | forward | 2,877,794 | 2,871,360 |
| Note | 2023 | 2022 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 2 | 2 | ||||||||
| Fixed assets | |||||||||
| Investments | 2,704,274 | 2,624,858 | |||||||
| Current assets | |||||||||
| Cash at bank | and | in | hand | 244,513 | 317,613 | ||||
| 244,513 | 317,613 | ||||||||
| Liabilities | |||||||||
| Creditors; amounts | falling due within | one year | 10 | (70,993) | (71,111) | ||||
| Net current assets | 173,520 | 246,502 | |||||||
| Total assets | less | current liabilities | 2,877,794 | 2,871,360 | |||||
| Funds | |||||||||
| Unrestricted | General | fund (including | revaluation | ||||||
| reserve) | 12 | 2,877,794 | 2,871,360 |
| Note | 2023 | 2022 | |||||
|---|---|---|---|---|---|---|---|
| 2 | 2 | ||||||
| Cash flows from operating | activities | ||||||
| Net movement in funds |
6,434 | 208,216 | |||||
| Decrease Increase in creditors |
10 | (118) | (37,409) | ||||
| Loss / (gains) on investments | 24,326 | (151,759) | |||||
| Net cash inflow from operating | activities | 30,642 | 19,048 | ||||
| Cash flows from investing | activities | ||||||
| Investment income reinvested in |
the fund | 9 | (110,080) | (93,061) | |||
| Proceeds from sale of investments | 6,338 | 4,347 | |||||
| Net cash outflow from investing | activities | (103,742) | (88,714) | ||||
| Net decrease in cash and | cash | equivalents | (73,100) | (69,666) | |||
| Cash and cash equivalents year |
at the | start of the | 317,613 | 387,279 | |||
| Cash and cash equivalents year |
at the end ofthe | 244,513 | 317,613 | ||||
| Cash and cash equivalents | consists of: | ||||||
| Cash at bank and in hand |
244,513 | 317,613 |
| section 252 ofthe charitable objects. |
Taxation of Char | Taxation of Char | geable Gains Act |
1992to the extent that these a | re applied to its | |
|---|---|---|---|---|---|---|
| 8 | (Losses) / Gains | on Investment | assets | |||
| Unrestricted | Unrestricted | |||||
| 2023 | 2022 | |||||
| 2 | 2 | |||||
| Realised gains | 198 | 239 | ||||
| Unrealised gains |
(24,524) | 151,520 | ||||
| (24,326) | 151,759 | |||||
| 9 | Fixed Asset Investments | |||||
| Unrestricted | Unrestricted | |||||
| 2023 | 2022 | |||||
| 2 | 2 | |||||
| Listed investments | (at valuation): | |||||
| Market value at 1 March | 2,624,858 | 2,384,385 | ||||
| Additions | 110,080 | 93,061 | ||||
| Disposals | (6,338) | (4,108) | ||||
| Unrealised net investment |
(loss) / gain | (24,326) | 151,520 | |||
| Market value at 28 | February | 2,704,274 | 2,624,858 | |||
| Cost at 28 February | 2,268,231 | 2,164,291 |
| follows at | the end | ofthe p | eriod: | ||||
|---|---|---|---|---|---|---|---|
| Iillarket | Market | ||||||
| Value | Value | ||||||
| 2023 | 2022 | ||||||
| 9 | 2 | ||||||
| Cazenove | Charity | UCITS | Fund | 31.43% | 904,540 | 31.5% | 827,061 |
| Cazenove | Charity | NURS | Fund | 62.54% | 1,799,734 | 68.5% | 1,797,797 |
| 10 | Creditors falling due within one year | Creditors falling due within one year | Creditors falling due within one year | Unrestricted | Unrestricted | |
|---|---|---|---|---|---|---|
| 2023 | 2022 | |||||
| 6 | 2 | |||||
| Grants payable Accruals |
66,313 4,680 |
65,721 5,390 |
||||
| 70,993 | 71,111 | |||||
| 11 | Analysis of Funds | Unrestricted | Unrestricted | |||
| 2023 | 2022 | |||||
| 2 | ||||||
| Unrestricted At 1 March |
general fund | 2,871,360 | 2,663,144 | |||
| Income | 110,080 | 93,061 | ||||
| Expenditure Investment gains |
(79,320) (24,326) |
(36,604) 151,759 |
||||
| At 28 February | 2,877,794 | 2,871,360 | ||||
| 12 | Analysis of Net Assets | Unrestricted | Unrestricted | |||
| 2023 | 2022 | |||||
| 2 | 2 | |||||
| Unrestricted | funds | |||||
| Investments | 2,704,274 | 2,624,858 | ||||
| Cash at bank | 244,513 | 317,613 | ||||
| Net current liabilities |
(70,993) | (71,111) | ||||
| 2,877,794 | 2,871,360 | |||||
| 13 | Financial Instruments |
|||||
| Financial assets that are debt instruments | measured | at amortised costs: | ||||
| Unrestricted | Unrestricted | |||||
| 2023 | 2022 | |||||
| 2 | 2 | |||||
| Cash at bank | and | in hand | 244,513 | 317,613 |